Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Falkensammer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Strahlentherapie. Sonderbande|January 1, 1975
[Follow-up results of 131-I therapy of benign thyroid diseases: an unsolved problem of dosimetry]M Falkensammer, D Ladurner, G Riccabona
Nuklearmedizin. Nuclear Medicine|January 1, 1979
[Estimation of lung water with 131I-antipyrine and 99mTc-HSA (author's transl)]M Falkensammer, U Noelpp, H Rösler
Nuclear-Medizin|May 31, 1973
[Functional scanning of the liver with 131-I-sulfobromophthalein]G Riccabona, M Falkensammer, H Bauer
Klinische Wochenschrift|August 1, 1976
Immunological characterization of lymphoproliferative disorders by membrane markersH Huber, G Michlmayr, C Huber, et al.
Nuclear-Medizin|August 15, 1972
[Sequential kidney scintigraphy using 113m In-EDTA and simultaneous determination of glomerular filtrates]H Bauer, M Falkensammer, M Höllwarth, et al.
Acta Endocrinologica. Supplementum|October 1, 1973
Epidemiologic distinctions of 2 neighbouring goiter districts, of which one has had iodine prophylaxis for 10 yearsH Bauer, J Glatzl, M Falkensammer, et al.
Schweizerische Medizinische Wochenschrift|June 8, 1974
[T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases]G Michlmayr, C Huber, U Fink, et al.
Wiener Klinische Wochenschrift|April 17, 1981
[Stepwise combination of skeletal scintigram and x-rays in the improvement and rationalisation of skeletal metastases detection (author's transl)]W Zechmann, M Falkensammer, H Wacker, et al.
Hamatologie Und Bluttransfusion|January 1, 1976
[Immunologic changes in non-Hodgkin's-lymphoma]H Huber, G Michlmayr, M Falkensammer, et al.
Schweizerische Medizinische Wochenschrift|June 5, 1976
[Rosette tests in lymphoproliferative diseases]G Michlmayr, C Pathouli, M Falkensammer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Strahlentherapie. Sonderbande|January 1, 1975
[Follow-up results of 131-I therapy of benign thyroid diseases: an unsolved problem of dosimetry]M Falkensammer, D Ladurner, G Riccabona
Nuklearmedizin. Nuclear Medicine|January 1, 1979
[Estimation of lung water with 131I-antipyrine and 99mTc-HSA (author's transl)]M Falkensammer, U Noelpp, H Rösler
Nuclear-Medizin|May 31, 1973
[Functional scanning of the liver with 131-I-sulfobromophthalein]G Riccabona, M Falkensammer, H Bauer
Klinische Wochenschrift|August 1, 1976
Immunological characterization of lymphoproliferative disorders by membrane markersH Huber, G Michlmayr, C Huber, et al.
Nuclear-Medizin|August 15, 1972
[Sequential kidney scintigraphy using 113m In-EDTA and simultaneous determination of glomerular filtrates]H Bauer, M Falkensammer, M Höllwarth, et al.
Acta Endocrinologica. Supplementum|October 1, 1973
Epidemiologic distinctions of 2 neighbouring goiter districts, of which one has had iodine prophylaxis for 10 yearsH Bauer, J Glatzl, M Falkensammer, et al.
Schweizerische Medizinische Wochenschrift|June 8, 1974
[T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases]G Michlmayr, C Huber, U Fink, et al.
Wiener Klinische Wochenschrift|April 17, 1981
[Stepwise combination of skeletal scintigram and x-rays in the improvement and rationalisation of skeletal metastases detection (author's transl)]W Zechmann, M Falkensammer, H Wacker, et al.
Hamatologie Und Bluttransfusion|January 1, 1976
[Immunologic changes in non-Hodgkin's-lymphoma]H Huber, G Michlmayr, M Falkensammer, et al.
Schweizerische Medizinische Wochenschrift|June 5, 1976
[Rosette tests in lymphoproliferative diseases]G Michlmayr, C Pathouli, M Falkensammer, et al.
Pageof 2